Hepatocellular carcinoma (HG) is often difficult to distinguish from secondary liver neoplasia (SLN) by physical and imaging diagnostic procedures alone. To this aim we have extended and improved a laboratory approach based on a serum lactate dehydrogenase isoenzyme ratio (LD4:LD5) by adding the carcinoembryonic antigen: a-fetoprotein ratio, alkaline phosphatase, and serum iron concentrations to obtain a highly efficient discriminant function. In two successive cohorts, for a total of 102 patients, all histologically diagnosed, with a prevalence of HG vs SLN of 3:1, we correctly classified 96% of cases (100% of SLN cases). Subsequent verification with the jackknife reallocation statistical algorithm confirmed these results. In conclusion, this discriminant function based on simple laboratory assays of a few analytes is an important tool in solving a diagnostic dilemma in cases of liver neoplasia.
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The unequivocal differential diagnosis of primary and secondary liver neoplasia (SLN) is critical for the type and timing of therapy, which now includes surgery even in some cases of SLN.5 Differential diagnosis usually requires such complex imaging procedures as ultrasound, radionuclide scintigraphy, computerized tomography, and, more recently, magnetic resonance imaging (1, 2); ultrasound-guided fine-needle aspiration; and, if necessary, liver biopsy via laparoscopy as a last resort (3) . Although imaging techniques used to detect liver tumors are increasing in sensitivity, they are by themselves poorly specific for discriminating hepatocarcinoma (HC) from SLN. Similarly, cytology on many occasions may not discriminate between HC and SLN (3, 4).
As for biochemical markers, high serum concentrations of a-fetoprotein (AFP) are considered to be strongly predictive for HC (5) (9) ; the GGT isoenzyme complexed with low-density lipoproteins was analyzed by a precipitation method (10) . Serum copper was analyzed with an atomic absorption procedure (PerkinElmer, Norwalk, CT). The modified nucleoside pseudouridine was estimated in serum by HPLC (11) .
The same methods were used to analyze the various biochemical indices through the 7 years of the study. Inaccuracy was controlled throughout the study by using both intra-and interlaboratory quality-control systems, and it was practically constant.
Statistical Analyses
We used a statistical procedure analogous to that previously used in the selection of a panel of ascitic biochemical indices to discriminate malignant ascites from those due to liver cirrhosis or hepatocarcinoma (12) . For univariate statistical analysis, the nonparametric Mann-Whitney test was used to compare the distribution of all the analyte values in both groups (HC and SLN patients). The indicators of diagnostic efficiency were evaluated according to Galen and Gambino (13) , and receiver-operating characteristic (ROC) plots were used to determine the discriminating cutoff values (14) . The statistical significance of the differences between the ROC plots was evaluated by comparing the areas under the curves (14) .
Before the multivariate analysis, the fitting of the different analytical variables to a gaussian distribution was checked with the probability plots and the Shapiro-Wilks method. These tests did not show any significant deviation from gaussian for any variable in original scale except LD4, AFP, and the CEAJAFP ratio. Therefore, the natural logarithms of AFP, LD4, and of the CEA/AFP ratio, which fitted a gaussian distribution, were used in all subsequent analyses.
Among Wilks' A (within-groups sum-of-squares :total sum-of-squares ratio) as a measure of group discrimination.
At the first step, the variable that contained the most discriminant power was selected; at each of the following steps the value of the selection criterion was reevaluated for all variables not in the model, and the one with the largest acceptable criterion value was included. The variables previously entered were reevaluated to check if they meet the removal criterion.
If a variable met this criterion, it was removed. Variable selection was concluded when no more variables met entry or removal criteria.
The discriminant score, calculated for each patient on the basis of the linear combination of variables selected by MDA, was used to classi!r cases into one of the two groups, on the basis of the Bayes rule (15) . The Bayes rule takes into account not only the probability of a case's belonging to one of the two groups on the basis of the discriminant score (conditional probability), but also the inherent probability of a case's belonging to one of the two groups in the absence of any information (prior probability). In our case, the observed proportions of cases in each group served as estimates of the prior probabilities because we considered our sample representative of the patient population. The sensitivity and the specificity of the discrimination function was estimated on the basis of the rate of misclassification of this reallocation method. Two statistical techniques were used to cross-validate the results of the MDA on the first cohort of patients. First, the jackknife procedure was used, in which one patient at time is excluded and the rule is rederived and used to classifr the excluded patient (16) . This algorithm removes much of the bias of the simple reallocation method (15) . Second, the validity of the discriminant function was tested prospectively among 45 patients (35 HC and 10 SLN) recruited in a successive period (1991-93).
After the positive check of the validity of the first discriminant function, a second function was calculated on the overall population, i.e., on a pool of the two cohorts studied. The validity of this second MDA was verified by the jackknife reallocation method. The relative weighting of each variable included in the discriminant model is designated by the standardized canonical discriminant coefficients, the sign (plus or minus) of which depicts whether there is a direct or inverse relation of the independent variables with the dependent variable (HC or SLN). However, the unstandardized coefficients of the final discriminant equation obviously also depend on the measurement units in which the individual analytes are expressed.
Results
A series of biochemical analytes, mostly enzymes and isoenzymes (LD and its isoenzymes, GGT and its isoenzymes, 5' -nucleotidase, leucine aminopeptidase, cholinesterase), proteins (AFP, CEA, and ferritin) and other markers (pseudouridine, copper, and iron) have been measured or calculated (the LD4:LD5 ratio, the CEA:AFP ratio) in a long-term study of cases that required a differential diagnosis between HC and SLN. SLN (see 18) . However, notwithstanding the high significance of all the analytes reported in Table 1, practically all of them showed some degree of overlapping in the two clinical situations as diagnosed by cytohistology of liver biopsy material. Therefore, in an attempt to enhance the discrimination power by combining several variables, we inserted all those listed in Table 1 in the SSPS computer program for MDA. The LD4, AFP, and CEA/AFP ratio were transformed into log scale to better fit gaussian distribution.
The program was run on the first cohort of patients that showed a prevalence of 3:1 for HC vs SLN, which was also inserted in the program. Among the nine variables in Table 1 , the statistical procedure selected four, (LD4:LD5, CEAAFP, iron, and AP) for a discriminant function by which 94% of the HC patients were correctly classified (100% of SLN patients). Table 2 shows the numerical values for the discriminant equation, the cutoff selected, and the cases correctly classified for the two diseases in 1987-1990 cohort of patients.
We next applied the discriminant function, previously found to be the best fit, to the cohort of patients admitted to the study between 1991 and 1993 examined at their presentation at our Gastroenterology Unit (Table 2) , and we confirmed that the diagnostic efficiency was 95% for HC (100% for SLN cases). Furthermore, the data obtained with all the measured analytes in the second cohort of patients (data not shown) confirmed that the best discriminant function possible was that obtained with the first cohort. Finally, we pooled the data of both cohorts and again confirmed that the best discrimination was obtained with the previously selected analytes (see Table 3 ). Nine cases from the original population of 77 HC and 25 SLN were excluded because they had one of the four analyte values missing. Indeed, the overall diagnostic efficiency (correctly classified cases) was even slightly higher (96%) than those obtained on the two individual cohorts, and the cutoff value was 0.94 instead of 0.85 (Table 3 ). The final equation is as follows: To evaluate the comparative differential diagnostic power of the discriminant function, we constructed a ROC curve for this discriminant function and compared it with ROC curves of the other variables that we had previously found to be significantly different for Table 2 . Differential diagnosis of HC and SLN by serum biochemical analytes after MDA in two consecutive In effect, it is not easy to distinguish between HC and SLN by physical and imaging examination of the liver, procedures that to our knowledge can reach a 50% efficiency (1, 2, 19) . The single or multiple nodules revealed in liver parenchyma by imaging suggest either a primary liver cancer or a secondary liver neoplasia from a primary localization in the abdomen, usually a colon cancer. Therefore, the physician must usually resort to fine-needle liver biopsy or laparoscopy followed by histological assessment; however, cellular atypia can confound cytology (3, 4) , and laparoscopy is an invasive procedure that is controindicated in some patients with clotting disorders.
CEA and the two isoenzymes LD4 and LD5 taken singly did not show any significant difference between the two diseases, whereas iron and AP, though highly significantly different between the two groups of patients, showed a diagnostic efficiency much lower than the discriminant function. Similarly, the LD4:LD5 ratio and the CEA:AYP ratio taken singly reached good levels of discrimination (>90% of HC correctly classified and 85% for SLN but combined reached almost the highest discrimination value in the overall population ( (17, 20) , the LD4 and LD5 isoenzymes are expressions of the altered anaerobic glycolysis switch (21, 22) typical of neoplastic cells, and altered AP is an expression of cell membrane malfunctioning (23) . Finally, perhaps serum iron concentrations, being so highly dependent on normal hepatic metabolism, respond differently if the cellular damage directly affects the hepatic cell (HC) or other cells proliferating within the liver (SLN).
In conclusion, whatever the biochemical mechanisms underlying the altered concentrations in blood serum of the analytes comprised in the discriminant equation, the suggested diagnostic approach is a rapid, simple, and noninvasive laboratory procedure by which HCaffected patients can be differentiated from SLN patients, thereby limiting recourse to invasive diagnostic procedures.
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